CLVT
Clarivate Plc NYSE Listed Oct 29, 2018$2.78
Pre-mkt
$2.83
+1.43%
Mkt Cap $1.8B
52w Low $1.66
36.0% of range
52w High $4.77
50d MA $2.53
200d MA $3.28
P/E (TTM)
-9.3x
EV/EBITDA
7.7x
P/B
0.4x
Debt/Equity
0.9x
ROE
-2.9%
P/FCF
6.2x
RSI (14)
—
ATR (14)
—
Beta
1.40
50d MA
$2.53
200d MA
$3.28
Avg Volume
7.4M
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
70 St. Mary Axe · London, Y9 EC3A 8BE · GB
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | TNS | 0.14 | 0.18 | +28.6% | 2.86 | -1.0% | +0.3% | -2.8% | +0.7% | -1.4% | +0.4% | — |
| Feb 24, 2026 | TNS | 0.16 | 0.20 | +25.0% | 2.35 | +0.9% | -2.1% | +4.3% | -4.2% | +0.4% | +6.9% | — |
| Oct 29, 2025 | TNS | 0.16 | 0.18 | +12.5% | 3.49 | -0.9% | -7.2% | +4.9% | +4.1% | -1.7% | +0.0% | — |
| Jul 30, 2025 | TNS | 0.18 | 0.18 | +0.0% | 4.05 | -0.2% | -4.9% | -6.0% | +1.7% | +0.3% | +2.4% | — |
| Apr 29, 2025 | TNS | 0.12 | 0.14 | +16.7% | 4.21 | -0.5% | +2.4% | -0.5% | +0.7% | -0.9% | -2.6% | — |
| Feb 19, 2025 | TNS | 0.20 | 0.21 | +5.0% | 4.76 | +0.0% | +1.7% | +0.0% | -5.6% | -2.2% | +1.8% | — |
| Nov 6, 2024 | TNS | 0.19 | 0.19 | +0.0% | 4.80 | +0.2% | -2.5% | -2.4% | +0.4% | +0.0% | +3.5% | — |
| Aug 6, 2024 | TNS | 0.18 | 0.20 | +11.1% | 5.40 | -1.7% | -5.9% | +12.0% | +0.0% | -3.2% | +12.5% | — |
| May 8, 2024 | TNS | 0.14 | 0.14 | +0.0% | 6.16 | -0.5% | +1.3% | +0.2% | -0.5% | +4.8% | -2.0% | — |
| Feb 27, 2024 | TNS | 0.21 | 0.23 | +9.5% | 7.38 | -1.5% | -4.2% | +1.6% | -0.6% | -1.1% | -0.7% | — |
| Nov 7, 2023 | TNS | 0.18 | 0.21 | +16.7% | 6.96 | +1.6% | -1.1% | -5.7% | +1.2% | -1.2% | +11.6% | — |
| Aug 3, 2023 | TNS | 0.19 | 0.21 | +10.5% | 6.98 | -2.3% | -2.0% | -1.8% | -1.8% | +6.8% | -0.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4 | Citigroup | Maintains | Neutral → Neutral | — | $2.47 | $2.47 | +0.0% | +2.0% | +2.8% | +5.8% | -4.7% | +1.1% |
| Feb 25 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $2.35 | $2.37 | +0.9% | -2.1% | +4.3% | -4.2% | +0.4% | +6.9% |
| Feb 25 | Barclays | Maintains | Underweight → Underweight | — | $2.35 | $2.37 | +0.9% | -2.1% | +4.3% | -4.2% | +0.4% | +6.9% |
| Jan 8 | Goldman Sachs | Downgrade | Buy → Neutral | — | $3.36 | $3.31 | -1.5% | +3.3% | -0.6% | -2.6% | -6.0% | +1.3% |
| Dec 17 | Morgan Stanley | Downgrade | Equal Weight → Underweight | — | $3.57 | $3.40 | -4.8% | -0.8% | -3.1% | +1.7% | -0.9% | -4.6% |
| Jul 18 | Jefferies | Downgrade | Buy → Hold | — | $4.31 | $4.22 | -2.1% | -1.9% | -0.2% | +3.8% | +2.1% | -0.7% |
| Feb 20 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $4.76 | $4.76 | +0.0% | +1.7% | +0.0% | -5.6% | -2.2% | +1.8% |
| Nov 7 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $4.80 | $4.81 | +0.2% | -2.5% | -2.4% | +0.4% | +0.0% | +3.5% |
| Nov 7 | Barclays | Maintains | Underweight → Underweight | — | $4.80 | $4.81 | +0.2% | -2.5% | -2.4% | +0.4% | +0.0% | +3.5% |
| Nov 6 | William Blair | Downgrade | Outperform → Market Perform | — | $6.59 | $5.25 | -20.3% | -27.2% | -2.5% | -2.4% | +0.4% | +0.0% |
| Aug 7 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $5.40 | $5.31 | -1.7% | -5.9% | +12.0% | +0.0% | -3.2% | +12.5% |
| Aug 7 | Barclays | Maintains | Underweight → Underweight | — | $5.40 | $5.31 | -1.7% | -5.9% | +12.0% | +0.0% | -3.2% | +12.5% |
| May 9 | Goldman Sachs | Maintains | Buy → Buy | — | $6.16 | $6.13 | -0.5% | +1.3% | +0.2% | -0.5% | +4.8% | -2.0% |
| Feb 28 | Barclays | Maintains | Underweight → Underweight | — | $7.38 | $7.27 | -1.5% | -4.2% | +1.6% | -0.6% | -1.1% | -0.7% |
| Feb 28 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $7.38 | $7.27 | -1.5% | -4.2% | +1.6% | -0.6% | -1.1% | -0.7% |
| Feb 28 | Oppenheimer | Maintains | Outperform → Outperform | — | $7.38 | $7.27 | -1.5% | -4.2% | +1.6% | -0.6% | -1.1% | -0.7% |
| Feb 28 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $7.38 | $7.27 | -1.5% | -4.2% | +1.6% | -0.6% | -1.1% | -0.7% |
| Jan 8 | Oppenheimer | Maintains | Outperform → Outperform | — | $8.67 | $8.75 | +0.9% | +6.0% | -1.8% | +0.0% | -0.6% | +1.2% |
| Dec 15 | Wells Fargo | Downgrade | Equal Weight → Underweight | — | $8.76 | $8.58 | -2.1% | -3.0% | -0.2% | +5.3% | +0.0% | +3.4% |
| Oct 5 | Oppenheimer | Maintains | Outperform → Outperform | — | $6.48 | $6.45 | -0.5% | +0.3% | -0.2% | -1.7% | +5.8% | +0.4% |
| Sep 26 | Citigroup | Maintains | Neutral → Neutral | — | $7.18 | $7.08 | -1.4% | -2.1% | +2.7% | -6.8% | -0.3% | +0.6% |
| Sep 8 | Barclays | Downgrade | Equal Weight → Underweight | — | $7.04 | $6.80 | -3.4% | -0.7% | +1.1% | +0.7% | -0.6% | +2.5% |
| Aug 25 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $7.10 | $6.99 | -1.5% | +0.6% | +0.8% | +1.0% | +0.0% | +2.2% |
| Aug 7 | BofA Securities | Downgrade | Neutral → Underperform | — | $6.84 | $6.63 | -3.0% | -1.8% | -1.8% | +6.8% | -0.7% | +1.6% |
| Aug 4 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $6.98 | $6.82 | -2.3% | -2.0% | -1.8% | -1.8% | +6.8% | -0.7% |
| Aug 4 | Oppenheimer | Maintains | Outperform → Outperform | — | $6.98 | $6.82 | -2.3% | -2.0% | -1.8% | -1.8% | +6.8% | -0.7% |
| Aug 4 | Goldman Sachs | Maintains | Buy → Buy | — | $6.98 | $6.82 | -2.3% | -2.0% | -1.8% | -1.8% | +6.8% | -0.7% |
| Aug 4 | RBC Capital | Maintains | Outperform → Outperform | — | $6.98 | $6.82 | -2.3% | -2.0% | -1.8% | -1.8% | +6.8% | -0.7% |
| Aug 4 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $6.98 | $6.82 | -2.3% | -2.0% | -1.8% | -1.8% | +6.8% | -0.7% |
| Aug 4 | Barclays | Maintains | Equal Weight → Equal Weight | — | $6.98 | $6.82 | -2.3% | -2.0% | -1.8% | -1.8% | +6.8% | -0.7% |
| Jul 5 | Oppenheimer | Maintains | Outperform → Outperform | — | $9.57 | $9.52 | -0.5% | -0.7% | -2.8% | +0.8% | +4.8% | -0.2% |
| Jun 13 | Oppenheimer | Maintains | Outperform → Outperform | — | $8.28 | $8.54 | +3.1% | +8.3% | -0.8% | +3.3% | -1.1% | -1.3% |
| May 10 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $7.84 | $7.92 | +1.0% | +2.8% | -0.6% | -0.1% | +3.0% | -7.8% |
| May 10 | Goldman Sachs | Maintains | Buy → Buy | — | $7.84 | $7.92 | +1.0% | +2.8% | -0.6% | -0.1% | +3.0% | -7.8% |
| Apr 17 | RBC Capital | Maintains | Outperform → Outperform | — | $9.01 | $8.95 | -0.7% | +0.1% | +1.0% | +1.2% | -3.3% | +1.6% |
| Mar 10 | RBC Capital | Maintains | Outperform → Outperform | — | $10.57 | $10.50 | -0.7% | -5.4% | +0.0% | +1.0% | -2.0% | -1.1% |
| Mar 2 | RBC Capital | Maintains | Outperform → Outperform | — | $11.42 | $11.38 | -0.4% | +0.4% | -1.0% | -2.5% | -2.1% | -0.5% |
| Mar 2 | Wells Fargo | Maintains | Overweight → Overweight | — | $11.42 | $11.38 | -0.4% | +0.4% | -1.0% | -2.5% | -2.1% | -0.5% |
| Feb 6 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $11.19 | $10.91 | -2.5% | -1.7% | +0.5% | -1.2% | -0.1% | +0.4% |
| Jan 4 | Morgan Stanley | Maintains | Overweight → Overweight | — | $8.54 | $8.68 | +1.6% | +2.6% | -0.6% | +3.0% | +6.1% | -0.3% |
| Nov 9 | Goldman Sachs | Maintains | Buy → Buy | — | $9.64 | $9.43 | -2.2% | -4.6% | +8.7% | +6.0% | -4.7% | +4.2% |
| Nov 9 | Morgan Stanley | Maintains | Overweight → Overweight | — | $9.64 | $9.43 | -2.2% | -4.6% | +8.7% | +6.0% | -4.7% | +4.2% |
| Nov 9 | Wells Fargo | Maintains | Overweight → Overweight | — | $9.64 | $9.43 | -2.2% | -4.6% | +8.7% | +6.0% | -4.7% | +4.2% |
| Nov 9 | RBC Capital | Maintains | Outperform → Outperform | — | $9.64 | $9.43 | -2.2% | -4.6% | +8.7% | +6.0% | -4.7% | +4.2% |
| Oct 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $9.91 | $9.80 | -1.1% | -4.9% | +0.0% | -2.0% | -0.4% | -0.4% |
| Sep 28 | RBC Capital | Maintains | Outperform → Outperform | — | $9.49 | $9.48 | -0.1% | +2.6% | -5.6% | +2.2% | +3.8% | +2.2% |
| Sep 27 | Morgan Stanley | Maintains | Overweight → Overweight | — | $9.87 | $10.00 | +1.3% | -3.9% | +2.6% | -5.6% | +2.2% | +3.8% |
| Sep 13 | Morgan Stanley | Maintains | Overweight → Overweight | — | $12.19 | $11.75 | -3.6% | -3.4% | -1.6% | -5.8% | -3.1% | -0.1% |
| Aug 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $12.87 | $12.95 | +0.6% | +4.0% | -3.2% | +1.4% | +3.7% | -1.1% |
| Aug 10 | RBC Capital | Maintains | Outperform → Outperform | — | $12.87 | $12.95 | +0.6% | +4.0% | -3.2% | +1.4% | +3.7% | -1.1% |
No insider trades available.
8-K · 7.01
! Medium
Clarivate Plc -- 8-K 7.01: Regulation FD Disclosure
Clarivate Plc disclosed supplemental financial information regarding revenue, earnings, and guidance on its investor relations website, providing investors updated performance metrics and forward-looking data.
Apr 29
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
CLVT's executive leadership transition on March 23, 2026 could signal strategic direction shifts or governance concerns, making it critical for investors to review who's departing and their replacement's background.
Mar 26
8-K · 7.01
! Medium
Clarivate Plc -- 8-K 7.01: Regulation FD Disclosure
Clarivate released supplemental financial information including revenue, earnings, and guidance updates on February 24, 2026, available on its investor relations website.
Feb 24
8-K · 7.01
! Medium
Clarivate Plc -- 8-K 7.01: Regulation FD Disclosure
Clarivate Plc released an AI-focused webinar and presentation materials on its investor relations website, providing stakeholders with insights into the company's artificial intelligence strategy and capabilities.
Feb 3
8-K · 8.01
!! High
Clarivate Plc -- 8-K 8.01: Material Event / Announcement
Clarivate Plc successfully discharged its 2026 Notes indenture, eliminating debt obligations and reducing financial leverage for the company.
Feb 2
Data updated apr 25, 2026 1:49am
· Source: massive.com